Your search history is turned on.
Date: March 14, 2024 Jurisdictions: Alberta, British Columbia, Ontario
STATEMENT OF EXECUTIVE COMPENSATION (for the financial year ended June 30, 2023) DOSEOLOGY SCIENCES INC. (the Company) Note: the figures contained in this Statement of Executive Compensation do not reflect the consolidation effected by the Company on February 16, 2024. For the purposes of this Statement of Executive Compensation, a Named Executive ...
Date: February 26, 2024 Jurisdictions: Alberta, British Columbia, Ontario
Unofficial consolidation for financial years beginning on or after January 1, 2011 1 This is an unofficial consolidation of Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate reflecting amendments made effective January 1, 2011 in connection with Canadas changeover to IFRS. The amendments apply for financial periods relating to finan...
Unofficial consolidation for financial years beginning on or after January 1, 2011 1 This is an unofficial consolidation of Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate reflecting amendments made effective January 1, 2011 in connection with Canadas changeover to IFRS. The amendments apply for financial periods relating to financial ...
Doseology Sciences Inc. Managements Discussion & Analysis For the three and six months ended December 31, 2023 and 2022 DOSEOLOGY SCIENCES INC. Managements Discussion and Analysis For the three and six months ended December 31, 2023 and 2022 Page 1 Th...
Doseology Sciences Inc. Condensed Interim Consolidated Financial Statements For the six months ended December 31, 2023 and 2022 (Unaudited - Expressed in Canadian dollars) NOTICE OF NO AUDITOR REVIEW OF TH...
Date: February 16, 2024 Jurisdictions: Alberta, British Columbia, Ontario
MATERIAL CHANGE REPORT FORM 51-102F3 MATERIAL CHANGE REPORT Item 1: Name and Address of Reporting Issuer Doseology Sciences Inc. (the Company) Suite 305, 93151 Lakeshore Rd. Kelowna, BC V1W 3S9 Item 2: Date of Material Change February 16, 2024. Item 3: News Release A news release was issued and disseminated February 14, 2024 and filed o...
Date: February 14, 2024 Jurisdictions: Alberta, British Columbia, Ontario
Doseology Announces Effective Date for Share Consolidation Kelowna, British Columbia, February 14, 2024 Doseology Sciences Inc. (CSE: MOOD) (OTCQB: DOSEF) (FSE: VU7) (Doseology or the Company), Doseology, an innovator in functional mushroom wellness products, announces, further to its news release of February 8, 2024, that the consolidation of its iss...
Date: February 8, 2024 Jurisdictions: Alberta, British Columbia, Ontario
Doseology Announces Proposed Share Consolidation Kelowna, British Columbia, February 8, 2024 Doseology Sciences Inc. (CSE: MOOD) (OTCQB: DOSEF) (FSE: VU7) (Doseology or the Company), Doseology, an innovator in functional mushroom wellness products, announces its intention to consolidate its outstanding common shares on the basis of ten (10) existing ...
Date: December 21, 2023 Jurisdictions: British Columbia
Create report of exempt distribution (Form 45-106F1) Form 45-106F1 Report of Exempt Distribution ITEM 1 - REPORT TYPE New report Amended report If amended, provide filing date of report that is being amended. (YYYY-MM-DD) ITEM 2 - PARTY CERTIFYING THE REPORT Indicate the party certifying the report (select only one). For guidance regarding whether an ...
Date: December 21, 2023 Jurisdictions: Alberta, British Columbia, Ontario
MATERIAL CHANGE REPORT FORM 51-102F3 MATERIAL CHANGE REPORT Item 1: Name and Address of Reporting Issuer Doseology Sciences Inc. (the Company) Suite 305, 93151 Lakeshore Rd. Kelowna, BC V1W 3S9 Item 2: Date of Material Change December 21, 2023. Item 3: News Release A news release was issued and disseminated December 21, 2023 and filed o...